
Based on this study, the monoclonal antibody is being investigated in an ongoing phase 3 study and has received an FDA Breakthrough Therapy Designation.

Based on this study, the monoclonal antibody is being investigated in an ongoing phase 3 study and has received an FDA Breakthrough Therapy Designation.

A cancer survivor offers how her faith helped her through her cancers.

A little insight into what kids see when you don't know they're looking, and how I came in second place to Thomas Edison.

It's exhausting trying to keep everybody positive about my progress.

Ruben A. Mesa addressed the current treatment landscape for PV last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals.

CURE interviewed Thomas Prebet to gain insight into the importance of supportive care in myelodysplastic syndrome.

A male breast cancer survivor looks at the science of life and death.

The approval was based on an extension in progression-free survival in the phase 3 coBRIM study.

Denise O'Dea, a nurse practitioner at Mount Sinai Medical Center, recently sat down with CURE to discuss side effects from treatment for NSCLC and what nurses can do to help patients manage their symptoms.

"It's not because there's evidence that they don't work — it's just that there's no evidence at all," Maurie Markman says.

Five years from now multiple myeloma will have a therapeutic backbone consisting entirely of combinations of novel agents, a leading myeloma researcher predicts.

A combination approach can improve responses through mechanisms that, "enhance immune function, enhance receptor expression, or target intracellular signaling."

According to a recent CDC study, 69 percent of cancer patients say they pray for their health. If I had to guess, I would say the other 31 percent are doing the same thing but just call it something else.

Last month, we got the chance to discuss DCIS with three doctors from NYU Cancer Center: Dr. Deborah Axelrod, Dr. Julia Smith, and Dr. David Kleinberg.

Ed chronicles his chronic lymphocytic leukemia (CLL) story from the third person.

When you join the cancer club, even as auxiliary member, you remember those who reminded you that you could get through it, and you pay it forward.

This breast cancer and melanoma survivor thinks blending old normal with new normal is more than blending before-cancer life into after-cancer life.

Women who performed 150 minutes of treadmill exercise per week and those who exercised twice that amount showed estrogen-sensitive breast tissue reductions of 8 percent and 12 percent, respectively.

As November is National Caregivers Month, it seems appropriate to honor those who stand by us during life's most challenging moments.

The recent World Health Organization announcement classifying processed meat as a Group 1 carcinogen isn't really news. It's just common sense.

The designation, which will expedite the development and review of Keytruda in this space, was based on findings from an ongoing phase 2 study.

How you make a decision is sometimes as important as the decision you make.

Something in the way she moves ...

With the flip of a coin, I became one with logic instead of reacting emotionally.

Some say I'm a lucky person. I say it's who I am.

This video was produced by The Esophageal Cancer Awareness Association. It features the compelling stories of EC survivors: former US Congresswoman Ellen Tauscher, Jeff Thomas and Roger Tunsley.

This video was produced by The Esophageal Cancer Awareness Association. It features the compelling stories of EC survivors: Brian Galgay and Karen Kent.

An academically trained skeptic, this single project has turned me into a raving optimist.

A glimpse into stereotactic radiosurgery for lung cancer spread to the brain.

XRAYS aims to be "a reliable resource designed to help young breast cancer survivors and high-risk women navigate through breast cancer research related news and information."